Publikationen von Anna Bujanow

Gkotsoulias, D.; Rullmann, M.; Schmitt, S.; Bujanow, A.; Zientek, F.; Messerschmidt, K.; Pampel, A.; Büttner, A.-P.; Schildan, A.; Sabri, O. et al.; Müller-Vahl, K.; Barthel, H.; Möller, H. E.: Abnormalities of iron homeostasis and the dopaminergic system in Tourette syndrome revealed by 7T MRI and PET. Brain Communications 7 (2), fcaf104 (2025)

Günther, V.; Jahn, S.; Webelhorst, C.; Bodenschatz, C. M.; Bujanow, A.; Mucha, S.; Kersting, A.; Hoffmann, K.-T.; Egloff, B.; Lobsien, D. et al.; Suslow, T.: Coping with anxiety: Brain structural correlates of vigilance and cognitive avoidance. Frontiers in Psychiatry 13, 869367 (2022)

Hoepfel, D.; Günther, V.; Bujanow, A.; Kersting, A.; Bodenschatz, C. M.; Suslow, T.: Experiences of maltreatment in childhood and attention to facial emotions in healthy young women. Scientific Reports 12 (1), 4317 (2022)

Bujanow, A.; Bodenschatz, C. M.; Szymanska, M.; Kersting, A.; Vulliez-Coady, L.; Suslow, T.: The relationship between dispositional attention to feelings and visual attention to emotion. Progress in Neuro-Psychopharmacology & Biological Psychiatry 100, 109882 (2020)

Günther, V.; Hußlack, A.; Weil, A.-S.; Bujanow, A.; Henkelmann, J.; Kersting, A.; Quirin, M.; Hoffmann, K.-T.; Egloff, B.; Lobsien, D. et al.; Suslow, T.: Individual differences in anxiety and automatic amygdala response to fearful faces: A replication and extension of Etkin et al. (2004). NeuroImage: Clinical 28, 102441 (2020)

Suslow, T.; Hußlack, A.; Bujanow, A.; Henkelmann, J.; Kersting, A.; Hoffmann, K.-T.; Egloff, B.; Lobsien, D.; Günther, V.: Implicitly and explicitly assessed anxiety: No relationships with recognition of and brain response to facial emotions. Neuroscience 408, S. 1 - 13 (2019)

Rullmann, M.; Gkotsoulias, D.; Schmitt, S.; Fremer, C.; Klages, C.; Hartung, K.; Bujanow, A.; Zientek, F.; Messerschmidt, K.; Patt, M. et al.; Sabri, O.; Müller-Vahl, K.; Möller, H. E.; Barthel, H.: A combined PET/MRI study on the interplay between dopamine D1 receptor availability and iron levels in Gilles de la Tourette syndrome (GTS). In European Journal of Nuclear Medicine and Molecular Imaging, 51 (Suppl. 1), S. S30 - S30. Springer-Verlag, Heidelberg, Germany (2024)

Rullmann, M.; Gkotsoulias, D.; Schmitt, S.; Fremer, C.; Klages, C.; Hartung, K.; Bujanow, A.; Zientek, F.; Messerschmidt, K.; Patt, M. et al.; Sabri, O.; Müller-Vahl, K.; Möller, H. E.; Barthel, H.: Dopamine D1 receptor availability in Gilles de la Tourette syndrome measured by [11C]SCH23390 PET. In European Journal of Nuclear Medicine and Molecular Imaging, 50 (Suppl. 1), S. S244 - S244. Springer-Verlag, Heidelberg, Germany (2023)

Messerschmidt, K.; Rullmann, M.; Gkotsoulias, D.; Schmitt, S.; Fremer, C.; Klages, C.; Hartung, K.; Bujanow, A.; Zientek, F.; Patt, M. et al.; Sabri, O.; Mueller-Vahl, K.; Möller, H. E.; Barthel, H.: The dopamine D1 receptor availability is reduced in Gilles de la Tourette syndrome: A C-11-SCH23390 PET study. In Journal of Nuclear Medicine, 64 (Suppl. 1), P597. Society of Nuclear Medicine, New York (2023)

Zhao, H.; Horn, U.; Freund, M.; Bujanow, A.; Gundlach, C.; Hartwigsen, G.; Eippert, F.: Assessing adverse effects and unspecific effects of transcutaneous spinal direct current stimulation (tsDCS). bioRxiv (2023)